Neoplastic Cells, Circulating

Research in neoplastic cells, circulating focuses on understanding and detecting cancer cells that have detached from a primary tumor and entered the bloodstream or lymphatic system. Investigations employ advanced techniques such as flow cytometry and novel biosensing methods to isolate, identify, and analyze these circulating tumor cells (CTCs). This work explores the biological characteristics of CTCs, including their role in metastasis, and examines their potential as biomarkers for early cancer detection, monitoring treatment response, and predicting prognosis. The development of liquid biopsy approaches is a key area of focus, aiming to provide less invasive diagnostic tools.

This research holds significant relevance for Arkansas’s public health landscape, particularly in addressing cancer burdens within the state. By developing more sensitive and accessible diagnostic tools, this work can contribute to earlier detection and improved patient outcomes. Furthermore, advancements in liquid biopsy and related technologies can foster innovation within Arkansas's growing biotechnology and healthcare sectors, creating economic opportunities and enhancing the state's capacity for advanced medical diagnostics and research.

This area of study draws upon expertise in nanotechnology for nanoparticle synthesis and applications in drug delivery, as well as in laser technology for cell analysis. Collaborations extend across multiple institutions within Arkansas, leveraging diverse skill sets to address complex questions in cancer biology and diagnostics.